Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
Elliott M. Antman(Brigham and Women's Hospital), Eugene Braunwald(Brigham and Women's Hospital), Zygmunt Sadowski, David A. Morrow(Brigham and Women's Hospital), Harvey D. White(University of Auckland), Sabina A. Murphy(Brigham and Women's Hospital), José López‐Sendón(Hospital Universitario La Paz), Frank Jiang(Sanofi (France)), Carolyn H. McCabe(Brigham and Women's Hospital), Mikhail Ruda(Institute of Experimental Cardiology), Andrzej Budaj, Sema Güneri(Dokuz Eylül University), Keith A.A. Fox(University of Edinburgh)
Cited by 605
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k